Entero Therapeutics Inc. Ordinary Shares ENTO 深 滬
等待開盤 10-02 09:30:00 美东时间
4.29
-0.710
-14.20%
華盛通- 最 高5.18
- 今 開4.65
- 成交量 374.58万股
- 最 低 4.10
- 昨 收 5.00
- 總市值 681.51万
- 52周最高 5.47
- 市盈率 靜 --
- 換手率 235.79%
- 52周最低 0.9693
- 委 比 90.33%
- 總股本 158.86万
- 歷史最高 894600.00
- 量 比 34.40
- 振 幅 21.60%
- 歷史最低 0.555
- 每 手 1
- 風險率 0.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Entero Therapeutics shares are trading higher after the company acquired 100% of GRID AI Corp.
Entero Therapeutics shares are trading higher after the company acquired 100% o...
今天 04:07
CELEBRITY RIVER CRUISES TO OPEN REMAINING INVENTORY ON 2027 SAILINGS ON SEPTEMBER 25
Following unprecedented demand for Priority Booking Access earlier this month, Celebrity River Cruises opens for sale to the public tomorrow. MIAMI, Sept. 24, 2025 /PRNewswire/ -- Celebrity ...
09-24 21:08
Top 5 Biotech Stocks With Strong Momentum
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
08-28 19:19
Apply Now: Accessibility Improvement Grant Portal Opens for L.A. Interim Housing Providers
Powered by L.A. Care and Health Net, funding will support accessibility improvement projects that will enhance safety and access for people with disabilities experiencing homelessness in Los...
08-27 23:00
Entero Therapeutics Q2 EPS $(0.21) Up From $(3.86) YoY
Entero Therapeutics (NASDAQ:ENTO) reported quarterly losses of $(0.21) per share. This is a 94.56 percent increase over losses of $(3.86) per share from the same period last year.
08-15 06:07
Why Is Entero Therapeutics Stock (ENTO) Up 55% Today?
Entero Therapeutics stock soared on Monday after the company announced a $3 mil...
08-11 20:57
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers IO Biotech (NASDAQ:IOBT) stock rose 52.5% to $2.76 during Monday's pre...
08-11 20:08
Entero Therapeutics jumps on $3M securities offering
Entero Therapeutics (NASDAQ:ENTO) signed deals with institutional investors to raise about $3 million through the sale of pre-funded and common stock warrants, priced at market under Nasdaq rules. The...
08-11 20:07
Entero Therapeutics Secures $3M Through Pre-Funded And Common Warrants
Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced
08-11 19:46
